• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病风险分层工具的评价:解读、定制和临床应用。

Review of tools of cardiovascular disease risk stratification: interpretation, customisation and application in clinical practice.

机构信息

Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.

出版信息

Singapore Med J. 2011 Feb;52(2):116-23.

PMID:21373738
Abstract

Cardiovascular Disease (CVD) is the leading cause of death in both developed and developing countries. While it is relatively easy to identify those who are obviously at high risk and those at the lowest risk for CVD, it is often the large group of individuals with what appears to be modestly abnormal risk factors who contributes most to the burden of CVD. This is where estimation of CVD risk is necessary. Many tools for risk assessment have been devised. All these risk scores have their own inherent advantages and disadvantages. Furthermore, they may also not be directly applicable to a local population. Ideally, each country should have its own risk score that takes into account other factors as well. In the interim, it is worthwhile to be familiar with one of these scores, select one that is most appropriate for your patient and discuss treatment options based on the estimated risk.

摘要

心血管疾病(CVD)是发达国家和发展中国家的主要死因。虽然识别那些明显处于高风险和最低风险的人相对容易,但通常是那些看似风险因素适度异常的人群,对 CVD 的负担贡献最大。这就是需要进行 CVD 风险评估的地方。已经设计了许多用于风险评估的工具。所有这些风险评分都有其自身的优点和缺点。此外,它们也可能不适用于当地人群。理想情况下,每个国家都应该有自己的风险评分,同时考虑到其他因素。在此期间,熟悉其中一个评分是值得的,选择一个最适合您的患者的评分,并根据估计的风险讨论治疗方案。

相似文献

1
Review of tools of cardiovascular disease risk stratification: interpretation, customisation and application in clinical practice.心血管疾病风险分层工具的评价:解读、定制和临床应用。
Singapore Med J. 2011 Feb;52(2):116-23.
2
Cardiovascular disease and bridging the diagnostic gap.心血管疾病与弥合诊断差距。
S D Med. 2013 Sep;66(9):366-9.
3
Barriers to cardiovascular disease risk scoring and primary prevention in Europe.欧洲心血管疾病风险评分和一级预防的障碍。
QJM. 2010 Oct;103(10):727-39. doi: 10.1093/qjmed/hcq122. Epub 2010 Aug 4.
4
Monitoring cardiovascular disease in Zimbabwe: a review of needs and options.
Cent Afr J Med. 1996 Apr;42(4):120-4.
5
Challenges for the management of hypertension in low-resource settings.资源匮乏地区高血压管理面临的挑战。
Ethn Dis. 2003 Summer;13(2 Suppl 2):S67-70.
6
Cardiovascular disease: application of a composite risk index from the Telehealth System in a district community.心血管疾病:远程医疗系统中的综合风险指数在社区的应用。
Public Health Nurs. 2004 Nov-Dec;21(6):524-32. doi: 10.1111/j.0737-1209.2004.21604.x.
7
Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.新的心血管风险评估策略在高危高血压患者中的优势。
Clin Ther. 2005 Oct;27(10):1658-68. doi: 10.1016/j.clinthera.2005.10.013.
8
Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.新西兰不同种族的弗雷明汉心血管风险评分表现:PREDICT CVD - 10。
N Z Med J. 2010 Feb 19;123(1309):50-61.
9
Cardiovascular disease knowledge and risk perception among underserved individuals at increased risk of cardiovascular disease.心血管疾病风险增加的弱势群体的心血管疾病知识与风险认知
J Cardiovasc Nurs. 2008 Jul-Aug;23(4):332-7. doi: 10.1097/01.JCN.0000317432.44586.aa.
10
Cardiovascular disease risk profiles among 'healthy' siblings of patients with early-onset cardiovascular disease: application of the new SCORE system.早发性心血管疾病患者“健康”兄弟姐妹的心血管疾病风险概况:新SCORE系统的应用
Eur J Cardiovasc Prev Rehabil. 2007 Aug;14(4):521-5. doi: 10.1097/HJR.0b013e328011c493.

引用本文的文献

1
Identifying adolescents at risk for depression: Assessment of a global prediction model in the Great Smoky Mountains Study.识别易患抑郁症的青少年:大烟山研究中全球预测模型的评估。
J Psychiatr Res. 2022 Nov;155:146-152. doi: 10.1016/j.jpsychires.2022.08.017. Epub 2022 Aug 20.
2
Risk assessment in the prevention of cardiovascular disease in low-resource settings.资源匮乏地区心血管疾病预防中的风险评估
Indian Heart J. 2016 May-Jun;68(3):391-8. doi: 10.1016/j.ihj.2015.07.004. Epub 2015 Aug 29.
3
Use of Chronic Kidney Disease to Enhance Prediction of Cardiovascular Risk in Those at Medium Risk.
利用慢性肾脏病提高中度风险人群心血管风险的预测能力。
PLoS One. 2015 Oct 23;10(10):e0141344. doi: 10.1371/journal.pone.0141344. eCollection 2015.
4
Applicability of the Existing CVD Risk Assessment Tools to Type II Diabetics in Oman: A Review.阿曼现有心血管疾病风险评估工具对II型糖尿病患者的适用性:一项综述。
Oman Med J. 2015 Sep;30(5):315-9. doi: 10.5001/omj.2015.65.
5
Variation among cardiovascular risk calculators in relative risk increases with identical risk factor increases.心血管风险计算器之间的差异表现为,相同的风险因素增加时,相对风险也相应增加。
BMC Res Notes. 2015 Sep 7;8:417. doi: 10.1186/s13104-015-1401-8.
6
Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study.弗雷明汉一般心血管疾病风险评分在多民族亚洲人群中的验证:一项回顾性队列研究。
BMJ Open. 2015 May 19;5(5):e007324. doi: 10.1136/bmjopen-2014-007324.
7
Comparative accuracy of different risk scores in assessing cardiovascular risk in Indians: a study in patients with first myocardial infarction.不同风险评分在评估印度人心血管风险中的比较准确性:一项针对首次心肌梗死患者的研究
Indian Heart J. 2014 Nov-Dec;66(6):580-6. doi: 10.1016/j.ihj.2014.10.399. Epub 2014 Nov 10.
8
Consensus statement on management of dyslipidemia in Indian subjects.关于印度人群血脂异常管理的共识声明。
Indian Heart J. 2014 Dec;66 Suppl 3(Suppl 3):S1-51. doi: 10.1016/j.ihj.2014.12.001. Epub 2014 Dec 24.
9
Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study.亚洲人群中合并队列风险评分的验证——一项回顾性队列研究
BMC Cardiovasc Disord. 2014 Nov 20;14:163. doi: 10.1186/1471-2261-14-163.
10
Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting.使用合并队列风险评分是否会高估他汀类药物的使用情况?一项在初级保健机构开展的回顾性队列研究。
BMC Fam Pract. 2014 Nov 12;15:172. doi: 10.1186/s12875-014-0172-y.